Divis Laboratories Share Price

ABOUT Divis Laboratories

• Industry Biotechnology & Drugs
• ISIN INE361B01024
• BSE Code 532488
• NSE Code DIVISLAB

Divi's Laboratories Limited is an India-based company, which is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs), intermediates and nutraceutical ingredients with predominance in exports. The Company’s products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Naproxen Sodium, Olmesartan Medoxomil, Pregabalin, Ticagrelor, Triprolidine HCl, Valacyclovir HCl, Valsartan, Venlafaxine HCl and Vigabatrin. In addition to generic business, the Company, through its custom synthesis business, supports pharma companies for their patented products business right from gram scale requirements for clinical trials to launch, as well as late life cycle management. The Company’s subsidiaries include Divis Laboratories (USA) Inc. and Divi’s Laboratories Europe AG.

MANAGEMENT

• Kiran Divi Chief Executive Officer, Whole-time Director
• L. Kishore Babu Chief Financial Officer
• M. Satish Choudhury Compliance Officer, Company Secretary
• Murali Divi Managing Director, Executive Director
• Nilima Divi Whole-Time Director - (Commercial)
• Nimmagadda Ramana Executive Director
• S. Devendra Rao Whole-time Director (Manufacturing)